E
BHVN

Ergoteles’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Ergoteles’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,401
Closed -$7.34M – 2266
2022
Q2 		$7.34M Buy
+50,401
New +$7.34M 0.22% 121
2022
Q1 		– Sell
-28,181
Closed -$3.88M – 1823
2021
Q4 		$3.88M Buy
+28,181
New +$3.88M 0.15% 148